Total Synthesis of Orbiculamide A
Organic Letters · 24.04.2026 · 28 (16) · 5114-5120
DOI: 10.1021/acs.orglett.6c00934 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 09.04.2026. Verfasst von Kayla C Newell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, University of British Columbia, 2036 Main Mall, V6T 1Z1 Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Peptides, Cyclic, Biological Products, 5-Hydroxytryptophan. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, British Columbia Knowledge Development Fund.
Abstract (Originalsprache)
Orbiculamide A, a macrocyclic peptide with antimitotic and antileukemic properties, contains several synthetically challenging structural motifs, including a 2-bromo-5-hydroxytryptophan residue, that presents a widely recognized synthetic challenge. Here, we report the first total synthesis of orbiculamide A, where central to our approach is a chemoselective, late-stage bromodesilylation strategy. This work provides a foundation for the synthesis of related natural products and scaffold diversification of medicinal peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemistry Department, University of British Columbia, 2036 Main Mall, V6T 1Z1 Vancouver, BC, Canada.
ORCID-Profile: Brian O Patrick, David M Perrin
Förderung
- Natural Sciences and Engineering Research Council of Canada
- British Columbia Knowledge Development Fund
Zitieren
APA
Newell, K. C., Sgarbi, C. M., Patrick, B. O., & Perrin, D. M. (2026). Total Synthesis of Orbiculamide A. Organic Letters, 28(16), 5114-5120. https://doi.org/10.1021/acs.orglett.6c00934
Vancouver
Newell KC, Sgarbi CM, Patrick BO, Perrin DM. Total Synthesis of Orbiculamide A. Organic Letters. 2026;28(16):5114-5120. doi:10.1021/acs.orglett.6c00934
BibTeX
@article{Newell2026,
author = {Newell, Kayla C and Sgarbi, Cassandra M and Patrick, Brian O and Perrin, David M},
title = {Total Synthesis of Orbiculamide A},
journal = {Organic Letters},
year = {2026},
volume = {28},
number = {16},
pages = {5114--5120},
doi = {10.1021/acs.orglett.6c00934}
}
EUVIMED